Table 2 Linear regression analysis of the association between SUA levels and cognitive measures.
SUA level (µmol/L) | No. of patients (%) | Crude | Model 1 | Model 2 | |||
|---|---|---|---|---|---|---|---|
ß (95%CI) | P | ß (95%CI) | P | ß (95%CI) | P | ||
MMSE | |||||||
Q1 (58.0–246.0) | 151(24.8) | 0 | 0 | 0 | |||
Q2 (247.0–287.0) | 150(24.7) | 0.02 (− 0.45, 0.50) | 0.921 | 0.01 (− 0.46, 0.47) | 0.977 | 0.28 (− 0.13, 0.69) | 0.183 |
Q3 (288.0–339.0) | 155(25.5) | − 0.03 (− 0.50, 0.43) | 0.887 | − 0.00 (− 0.48, 0.47) | 0.984 | 0.43 (0.01, 0.85) | 0.046 |
Q4 (340.0–611.0) | 152(25.0) | − 0.49 (− 0.96, − 0.02) | 0.041 | − 0.60 (− 1.11, − 0.10) | 0.02 | 0.45 (− 0.03, 0.92) | 0.065 |
P for trend | − 0.15 (− 0.30, − 0.00) | 0.045 | − 0.18 (− 0.34, − 0.02) | 0.029 | 0.15 (0.00, 0.30) | 0.047 | |
Q1–Q3 (58.0–339.0) | 356(75.0) | 0 | 0 | 0 | |||
Q4 (340.0–611.0) | 152(25.0) | − 0.49 (− 0.87, − 0.10) | 0.013 | − 0.60 (− 1.00, − 0.21) | 0.003 | 0.15 (− 0.22, 0.52) | 0.421 |
SUA per 20-unit increase | 608(100) | − 0.06 (− 0.11, − 0.02) | 0.006 | − 0.08 (− 0.13, − 0.04) | < 0.001 | 0.02 (− 0.03, 0.06) | 0.396 |
MoCA | |||||||
Q1 (58.0–246.0) | 151(24.8) | 0 | 0 | 0 | |||
Q2 (247.0–287.0) | 150(24.7) | − 0.17 (− 0.69, 0.35) | 0.519 | − 0.13 (− 0.65, 0.39) | 0.629 | 0.24 (− 0.19, 0.67) | 0.268 |
Q3 (288.0–339.0) | 155(25.5) | − 0.12 (− 0.64, 0.40) | 0.647 | − 0.02 (− 0.55, 0.50) | 0.926 | 0.56 (0.12, 1.00) | 0.012 |
Q4 (340.0–611.0) | 152(25.0) | − 0.78 (− 1.30, − 0.26) | 0.004 | − 0.82 (− 1.38, − 0.26) | 0.004 | 0.60 (0.10, 1.09) | 0.018 |
P for trend | − 0.23 (− 0.39, − 0.06) | 0.007 | − 0.23 (− 0.41, − 0.05) | 0.011 | 0.22 (0.06, 0.37) | 0.007 | |
Q1–Q3 (58.0–339.0) | 356(75.0) | 0 | 0 | 0 | |||
Q4 (340.0–611.0) | 152(25.0) | − 0.68 (− 1.10, − 0.26) | 0.002 | − 0.77 (− 1.21, − 0.32) | < 0.002 | 0.25 (− 0.13, 0.64) | 0.198 |
SUA per 20-unit increase | 608(100) | − 0.09 (− 0.14, − 0.04) | < 0.001 | − 0.10 (− 0.15, − 0.05) | < 0.001 | 0.04 (− 0.01, 0.09) | 0.111 |